GLOBAL BLOOD THERAPEUTICS IN (GBT) Earnings History & Surprises

NASDAQ:GBT • US37890U1088

Current stock price

68.49 USD
+0.01 (+0.01%)
At close:
68.49 USD
0 (0%)
After Hours:

GBT Earnings overview

Past quarterly earnings results for GLOBAL BLOOD THERAPEUTICS IN (GBT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Nov 3, 2022
Period
Q3 / 2022
EPS Estimate
-$1.13
Revenue Estimate
76.151M

Last Reported

Most Recent
Release Date
Aug 8, 2022
Period
Q2 / 2022
EPS Reported
-$1.26
EPS Surprise
-6.32%
Revenue Surprise
9.44%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q2 2022 -1.26 -1.19 -6.32% -12.50% 71.55M 65.376M 9.44% 50.46%
Q1 2022 -1.26 -1.32 4.42% -4.13% 55.16M 56.703M -2.72% 41.29%
Q4 2021 -1.36 -1.14 -19.41% -36.00% 56.099M 55.998M 0.18% 35.83%
Q3 2021 -1.13 -1.13 -0.39% -16.49% 52.052M 54.231M -4.02% 41.10%
Q2 2021 -1.12 -1.20 6.70% -30.23% 47.555M 44.362M 7.20% 50.97%
Q1 2021 -1.21 -1.02 -18.79% -0.83% 39.04M 43.431M -10.11% 176.49%
Q4 2020 -1.00 -0.95 -4.92% - 41.3M 39.421M 4.77% -
Q3 2020 -0.97 -0.76 -26.90% - 36.89M 43.04M -14.29% -
Q2 2020 -0.86 -1.16 26.07% - 31.5M 19.221M 63.89% -
Q1 2020 -1.20 -1.52 21.10% - 14.12M 4.822M 192.80% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

GBT EPS Q2Q GrowthGBT EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 Q1/25 Q2/25 0 50 100 150

Revenue Historical Q2Q growth and Acceleration

GBT Revenue Q2Q GrowthGBT Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 Q1/25 Q2/25 50 100 150

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

GBT Overview GBT Technical Analysis Report GBT Fundamental Analysis Report GBT Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

GLOBAL BLOOD THERAPEUTICS IN / GBT Earnings FAQ

What is the most recent earnings date for GBT stock?

GLOBAL BLOOD THERAPEUTICS IN (GBT) last reported earnings on 8/8/2022.

Did GLOBAL BLOOD THERAPEUTICS IN (GBT) beat earnings estimates last quarter?

GLOBAL BLOOD THERAPEUTICS IN (GBT) missed EPS estimates and beat revenue estimates in the most recent quarter.